Switch theme
Sign up to access all valuation multiples
Becton, Dickinson is the world's largest manufacturer and distributor of medical surgical products, such as needles, syringes, and sharps-disposal units. The company also manufactures prefilled devices, diagnostic instruments and reagents, as well as flow cytometry and cell-imaging systems. BD Medical is nearly half of the total business, while BD Life Sciences (27% of 2024 revenue) and BD Interventional (24%) account for the remainder. International revenue accounts for 43% of the company's business.
1906
72K+
LTM Revenue $21.3B
LTM EBITDA $6.2B
$68.1B
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
Becton Dickinson has a last 12-month revenue (LTM) of $21.3B and a last 12-month EBITDA of $6.2B.
In the most recent fiscal year, Becton Dickinson achieved revenue of $20.2B and an EBITDA of $4.8B.
Becton Dickinson expects next 12-month revenue of XXX and NTM EBITDA of XXX
See Becton Dickinson valuation multiples based on analyst estimates| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue | $21.3B | XXX | $20.2B | XXX | XXX | XXX |
| Gross Profit | $11.4B | XXX | $9.1B | XXX | XXX | XXX |
| Gross Margin | 54% | XXX | 45% | XXX | XXX | XXX |
| EBITDA | $6.2B | XXX | $4.8B | XXX | XXX | XXX |
| EBITDA Margin | 29% | XXX | 24% | XXX | XXX | XXX |
| EBIT | $5.2B | XXX | $2.9B | XXX | XXX | XXX |
| EBIT Margin | 25% | XXX | 14% | XXX | XXX | XXX |
| Net Profit | $4.0B | XXX | $1.7B | XXX | XXX | XXX |
| Net Margin | 19% | XXX | 8% | XXX | XXX | XXX |
| Net Debt | XXX | XXX | $18.4B | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of May 30, 2025, Becton Dickinson's stock price is $173.
Becton Dickinson has current market cap of $49.5B, and EV of $68.1B.
See Becton Dickinson trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $68.1B | $49.5B | XXX | XXX | XXX | XXX | $13.85 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Start Free TrialAs of May 30, 2025, Becton Dickinson has market cap of $49.5B and EV of $68.1B.
Becton Dickinson's trades at 3.3x EV/Revenue multiple, and 13.1x EV/EBITDA.
Equity research analysts estimate Becton Dickinson's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Becton Dickinson has a P/E ratio of 12.4x.
See valuation multiples for Becton Dickinson and 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $49.5B | XXX | $49.5B | XXX | XXX | XXX |
| EV (current) | $68.1B | XXX | $68.1B | XXX | XXX | XXX |
| EV/Revenue | 3.2x | XXX | 3.3x | XXX | XXX | XXX |
| EV/EBITDA | 11.0x | XXX | 13.1x | XXX | XXX | XXX |
| EV/EBIT | 13.0x | XXX | 19.5x | XXX | XXX | XXX |
| EV/Gross Profit | 6.0x | XXX | n/a | XXX | XXX | XXX |
| P/E | 12.4x | XXX | 21.5x | XXX | XXX | XXX |
| EV/FCF | 22.9x | XXX | 22.1x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Start Free TrialBecton Dickinson's last 12 month revenue growth is 6%
Becton Dickinson's revenue per employee in the last FY averaged $0.3M, while opex per employee averaged $0.1M for the same period.
Becton Dickinson's rule of 40 is 29% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Becton Dickinson's rule of X is 44% (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
See operational valuation multiples for Becton Dickinson and other 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 6% | XXX | 6% | XXX | XXX | XXX |
| EBITDA Margin | 29% | XXX | 25% | XXX | XXX | XXX |
| EBITDA Growth | 5% | XXX | 19% | XXX | XXX | XXX |
| Rule of 40 | 29% | XXX | 31% | XXX | XXX | XXX |
| Bessemer Rule of X | XXX | XXX | 44% | XXX | XXX | XXX |
| Revenue per Employee | XXX | XXX | $0.3M | XXX | XXX | XXX |
| Opex per Employee | XXX | XXX | $0.1M | XXX | XXX | XXX |
| S&M Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| G&A Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| R&D Expenses to Revenue | XXX | XXX | 6% | XXX | XXX | XXX |
| Opex to Revenue | XXX | XXX | 31% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| Ansell | XXX | XXX | XXX | XXX | XXX | XXX |
| Polymed | XXX | XXX | XXX | XXX | XXX | XXX |
| Farmaceutica Remedia | XXX | XXX | XXX | XXX | XXX | XXX |
| Etropal | XXX | XXX | XXX | XXX | XXX | XXX |
| Sopharma | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Becton Dickinson acquired XXX companies to date.
Last acquisition by Becton Dickinson was XXXXXXXX, XXXXX XXXXX XXXXXX . Becton Dickinson acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Start Free Trial| When was Becton Dickinson founded? | Becton Dickinson was founded in 1906. |
| Where is Becton Dickinson headquartered? | Becton Dickinson is headquartered in United States of America. |
| How many employees does Becton Dickinson have? | As of today, Becton Dickinson has 72K+ employees. |
| Who is the CEO of Becton Dickinson? | Becton Dickinson's CEO is Mr. Thomas E. Polen, Jr. |
| Is Becton Dickinson publicy listed? | Yes, Becton Dickinson is a public company listed on NYS. |
| What is the stock symbol of Becton Dickinson? | Becton Dickinson trades under BDX ticker. |
| When did Becton Dickinson go public? | Becton Dickinson went public in 1963. |
| Who are competitors of Becton Dickinson? | Similar companies to Becton Dickinson include e.g. Ansell, Polymed, Farmaceutica Remedia, Etropal. |
| What is the current market cap of Becton Dickinson? | Becton Dickinson's current market cap is $49.5B |
| What is the current revenue of Becton Dickinson? | Becton Dickinson's last 12 months revenue is $21.3B. |
| What is the current revenue growth of Becton Dickinson? | Becton Dickinson revenue growth (NTM/LTM) is 6%. |
| What is the current EV/Revenue multiple of Becton Dickinson? | Current revenue multiple of Becton Dickinson is 3.2x. |
| Is Becton Dickinson profitable? | Yes, Becton Dickinson is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of Becton Dickinson? | Becton Dickinson's last 12 months EBITDA is $6.2B. |
| What is Becton Dickinson's EBITDA margin? | Becton Dickinson's last 12 months EBITDA margin is 29%. |
| What is the current EV/EBITDA multiple of Becton Dickinson? | Current EBITDA multiple of Becton Dickinson is 11.0x. |
| What is the current FCF of Becton Dickinson? | Becton Dickinson's last 12 months FCF is $3.0B. |
| What is Becton Dickinson's FCF margin? | Becton Dickinson's last 12 months FCF margin is 14%. |
| What is the current EV/FCF multiple of Becton Dickinson? | Current FCF multiple of Becton Dickinson is 22.9x. |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
